Charlotte's Web First Quarter 2026 Financial Results
Louisville, Colorado--(Newsfile Corp. - May 13, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter ended March 31, 2026. All amounts are expressed in U.S. dollars. TRANSACTION AND SUBSEQUENT EVENTS UPDATE Propose
2026-05-13 7:07 AM EDT | Charlotte's Web Holdings, Inc.
Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market
Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing for its official entry into the United States market. This expansion marks a pivotal milestone in the Company's North American growth strategy under its new leadership team. While the brand previously maintained a broader internatio
Technology, Biotechnology, Health
2026-05-13 6:00 AM EDT | Restart Life Sciences Corp.
TelyRx Announces First Quarter 2026 Financial Results
Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced financial results for the first quarter ended March 31, 2026. All dollar amounts are expressed in U.S. dollars. Highlights for the First Quarter of 2026 Revenue increased to $19.4 million, compared to $14.3 million in Q
Healthcare and Hospitals, Health
2026-05-12 5:57 PM EDT | TelyRx
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news release dated April 22, 2026, it has closed an initial tranche (the "Initial Tranche") of its previously announced $1,000,000 non-brokered private placement (the "Offering"), which Initial Tranche consisted of the issuance of 13,600,000 units (e
Biotechnology, Pharmaceuticals, Health
2026-05-12 5:02 PM EDT | PreveCeutical Medical Inc.
DiagnosTear Secures Exclusive Global Rights to CLARIFY Eye Imaging Platform for Needle-Free Blood Diagnostics
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a leader in rapid, eye-based diagnostic technologies, is pleased to announce that on May 12, 2026, it has entered into a definitive exclusive global license agreement for the commercialization of the CLARIFY eye imaging platform, A breakthrough technology enabling blood analysis through a simple eye scan, eliminating the need for ne
2026-05-12 4:05 PM EDT | DiagnosTear Technologies Inc.
TelyRx to Host First Quarter 2026 Financial Results Conference Call on Wednesday, May 13, 2026 at 8:30 am ET
Clearwater, Florida--(Newsfile Corp. - May 12, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its first quarter 2026 financial results on Wednesday, May 13, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its first quarter 2026 financial results for the period ended March 31, 2026, after market cl
Healthcare and Hospitals, Health
2026-05-12 10:45 AM EDT | TelyRx
DIMERx Preclinical Data Confirms DMX-101 Non-Addictive Profile: No Reinforcement, No Dependence
San Francisco, California--(Newsfile Corp. - May 12, 2026) - DIMERx, Inc. ("DIMERx" or "the Company") is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis of drug misuse and dependence, with a portfolio of first-
Biotechnology, Pharmaceuticals, Health
2026-05-12 9:00 AM EDT | DIMERx INC.
CBD of Denver, Inc. Identifies Strategic Opportunities to Maximize Shareholder Value
Zurich, Switzerland--(Newsfile Corp. - May 12, 2026) - CBD of Denver Inc. (OTC Pink: CBDD) ("the Company") today announced that its management is actively pursuing potential strategic opportunities designed to position the Company for long-term growth and enhance value for its shareholders. Management is currently evaluating several prospective candidates, assets, and strategic initiatives that align with the Company's long-term vision and growth strategy. The Board of Directors believe
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-05-12 9:00 AM EDT | CBD of Denver Inc.
Functional Brands Inc. Announces Conversion Price Adjustment Agreement for Series C Preferred Stock
Lake Oswego, Oregon--(Newsfile Corp. - May 12, 2026) - Functional Brands Inc. (NASDAQ: MEHA), (the "Company"), a leading innovator in wellness and performance products, today announced that it has entered into a Conversion Price Reduction and Waiver Agreement with all holders of the Company's Series C Convertible Preferred Stock. Under the terms of the Agreement, the conversion price applicable to the Series C Preferred Stock during the Fixed Conversion Period has been modified to $0.16
Household / Consumer / Cosmetics, Health
2026-05-12 8:00 AM EDT | Functional Brands Inc.
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
British Columbia and Rehovot, Israel--(Newsfile Corp. - May 12, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its CDMO division has s
Biotechnology, Pharmaceuticals, Health
2026-05-12 7:30 AM EDT | BioHarvest Sciences Inc.
Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - May 12, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing tec
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-05-12 7:00 AM EDT | Phio Pharmaceuticals Corp.
Beckett's Closes US$500,000 5-Year 8% Convertible Debenture Financing
Ontario and Los Angeles, California--(Newsfile Corp. - May 11, 2026) - Beckett's Inc. (CSE: BKTS) ("Beckett's" or the "Company") is pleased to announce that it has closed its previously announced non-brokered private placement of 5-year 8% secured convertible debentures of the Company (the "Debentures") for aggregate gross proceeds of US$500,000 (the "Financing"). No finder's fees, commissions or other compensation were paid in connection with the Financi
Food / Beverages, Cannabis, Health
2026-05-11 6:00 PM EDT | Becketts Inc.
TERSIS Technologies Appoints Steven R. Miller, Sr. as Senior Advisor - Global Business Development & Strategic Partnerships
Brooksville, Florida--(Newsfile Corp. - May 11, 2026) - Tersis Technologies, Inc. (OTCID: TERS), a company focused on acquiring and deploying technologies that convert waste streams into regenerative energy, valuable commodities, and sustainable infrastructure solutions, today announced the appointment of Steven R. Miller, Sr. as Senior Advisor - Global Business Development & Strategic Partnerships.
Agriculture, Energy, Alternative Energy, Health
2026-05-11 10:45 AM EDT | Tersis Technologies Inc.
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 11, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine through its subsidiary Adia Med of Winter Park, LLC, today announced that all four of its planned clinical studies have received Institutional Review Board (IRB) approval. This milestone enables the continued execution and launch of human trials evaluating the safety and potential efficacy of the Company's proprietary AdiaVita™ stem cell a
Healthcare and Hospitals, Health
2026-05-11 10:04 AM EDT | Adia Nutrition Inc.
Functional Brands Inc. Signs Binding Letter of Intent for the Acquisition of the Assets of BullionFX | Alchemy for $142.9 million
Lake Oswego, Oregon--(Newsfile Corp. - May 11, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, today announced it has executed a binding Letter of Intent ("LOI") to acquire the assets of BullionFX, including its core product Alchemy (collectively, the "BullionFX Assets"), in an all-stock transaction valued at approximately $142.9 million. The transaction contemplated by the LOI represents a strategic asset acquisi
Household / Consumer / Cosmetics, Health
2026-05-11 8:00 AM EDT | Functional Brands Inc.
Edison Issues Report on Omantel (OTEL)
London, United Kingdom--(Newsfile Corp. - May 11, 2026) - Edison issues report on Omantel (MSX: OTEL). Omantel is a leading integrated telecom operator in Oman with a strategic regional footprint through its stake in Zain, combining a stable domestic telecom base with exposure to broader MENA markets. The investment case is increasingly centred on its transition towards a more diversified digital infrastructure and technology platform, driven by the scaling of ICT and international whol
Banking / Financial Services, Computer Hardware, Computer Software, Health
2026-05-11 7:43 AM EDT | Edison Group
Cheelcare Reports Second Consecutive Month of Record Companion Bookings with April Bookings up 147% Year-over-Year and 38.5% Sequentially
Markham, Ontario--(Newsfile Corp. - May 11, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced preliminary record monthly bookings for April 2026 for its Companion power assist product line, representing the second consecutive month for record bookings for growth. Bookings for April 2026 increased 147% year-over-year and 38.5% compared to March 2026, representing the second consecutive mon
2026-05-11 7:30 AM EDT | Cheelcare Inc.
National Nursing Week 2026 Celebrates the Power of Nurses to Transform Health
Ottawa, Ontario--(Newsfile Corp. - May 11, 2026) - The Canadian Nurses Association (CNA) proudly celebrates National Nursing Week, taking place May 11-17, 2026, with the theme The Power of Nurses to Transform Health. This theme highlights the incredible impact nurses have in shaping health care, driving innovation, and advocating for patient-centred care, while underscoring the vital necessity for nurses to lead at policy tables, ensuring their expertise dictates the future of a sustai
2026-05-11 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
La Semaine nationale des soins infirmiers 2026 célèbre le pouvoir des infirmières et infirmiers de transformer la santé
Ottawa, Ontario--(Newsfile Corp. - 11 mai 2026) - L'Association des infirmières et infirmiers du Canada (AIIC) célèbre fièrement la Semaine nationale des soins infirmiers, qui se déroule du 11 au 17 mai 2026, sous le thème Le pouvoir des infirmières et infirmiers de transformer la santé. Ce thème met en lumière l'incroyable impact des infirmières et infirmiers dans la transformation des soins de santé, l'innovation et la promo
2026-05-11 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Toronto, Ontario--(Newsfile Corp. - May 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leader in consumer heart monitoring, remote patient monitoring, and medical electrocardiogram ("ECG") software solutions, announces that it has elected to rely on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-933 allow
Technology, Healthcare and Hospitals, Health
2026-05-08 4:01 PM EDT | CardioComm Solutions, Inc.